LabCorp
LabCorp
358 South Main Street
Burlington
NC
27215
United States
Tel: 336-229-1127
Fax: 336-513-4510
Website: http://www.jobs.labcorp.com/
About LabCorp
LabCorp is a leading global life sciences company. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care.
LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories.
With scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, LabCorp processes tests on approximately 500,000 specimens each day, applying advances in medicine and science to laboratory testing.
LabCorp operates a sophisticated laboratory network, with corporate headquarters in Burlington, NC, and more than 50,000 employees worldwide. Our 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH.
291 articles about LabCorp
-
Amy Summy, Chief Marketing Officer of Labcorp, Named to Forbes’ CMO Next
2/16/2021
Labcorp, a leading global life sciences company, announced that Amy Summy, executive vice president and chief marketing officer, was recognized on the 2021 Forbes CMO Next list for her leadership during the COVID-19 crisis, while also spearheading the rebranding strategy that highlighted the power of Labcorp’s combined diagnostic and drug development businesses.
-
Labcorp Announces 2020 Fourth Quarter and Full Year Results and Provides 2021 Guidance
2/11/2021
Revenue: Q4 of $4.5 billion, up from $3.0 billion last year; Full year of $14.0 billion, up from $11.6 billion last year Diluted EPS: Q4 of $9.54, up from $2.32 last year; Full year of $15.88, up from $8.35 last year Adjusted EPS: Q4 of $10.56, up from $2.86 last year; Full year of $23.94, up from $11.32 last year
-
Labcorp Announces Key Appointments to Oncology Leadership Team
2/9/2021
Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointments of Prasanth Reddy, MD, MPH, and Robert Phillips, PhD, to its oncology team, advancing Labcorp’s leadership position and capabilities in cancer diagnosis, treatment, and drug development.
-
Labcorp Named to FORTUNE® Magazine’s 2021 ‘World’s Most Admired Companies,’ Making the Annual List for the Third Time
2/1/2021
Labcorp, a leading global life sciences company, announced that it has been named to FORTUNE® magazine's 2021 List of World’s Most Admired Companies, making the annual list for the third time.
-
BioSpace Movers & Shakers, Jan. 22
1/22/2021
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers. -
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 12, 2021.
-
Labcorp to Announce Fourth Quarter and Full Year 2020 Financial Results on February 11, 2021
1/8/2021
Labcorp (NYSE: LH), a leading global life sciences company, will release its fourth quarter and full year 2020 financial results before the market opens on Thursday, Feb. 11, 2021, and then will host a conference call and webcast beginning at 9:00 a.m. ET to discuss the results. The earnings release and accompanying financial information will be posted on the Labcorp Investor Relations website . Interested parties
-
News, much of it good, keeps coming in about the efficacy of the various COVID-19 vaccines. Here’s a look.
-
Labcorp Awarded CDC Contract to Study Variants of COVID-19 Virus and Improve Public Health Response
1/7/2021
Labcorp, a leading global life sciences company, announced that it has been awarded a contract from the Centers for Disease Control and Prevention to provide genomic sequencing of samples of SARS-CoV-2, the virus that causes COVID-19.
-
Brian Caveney, Chief Medical Officer and President of Labcorp Diagnostics, Named to Modern Healthcare's 100 Most Influential People in Healthcare
1/6/2021
Labcorp, a leading global life sciences company, announced that Dr. Brian Caveney, chief medical officer and president of Labcorp Diagnostics, was recognized by Modern Healthcare as one of the 100 most influential people in healthcare in 2020.
-
Labcorp Is Scheduled to Virtually Participate at the 39th Annual J.P. Morgan Healthcare Conference
1/5/2021
Labcorp, a leading global life sciences company, announced that members of the executive management team will participate in a virtual fireside chat at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12 at 8:20 a.m..
-
Walgreens and Labcorp Make Pixel by Labcorp™ At-Home COVID-19 Collection Kit Available Through Walgreens Find Care®
12/21/2020
Kit Can Allow More People to Get Tested, Helping Reduce the Spread of the Virus and Improving the Health of Communities
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 15, 2020.
-
All eyes on the FDA as they review a COVID-19 vaccine, FDA approval of an Emergency Use Authorization to LabCorp’s home test kit for COVID-19, the first testing device that does not require a prescription and more news.
-
LabCorp Receives FDA Authorization to Make At-Home COVID-19 Collection Kits Available Through Retail
12/9/2020
LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the Pixel by LabCorp™ COVID-19 Test Home Collection Kit to become the first to be available over the counter without requiring a prescription
-
LabCorp Is Scheduled to Present at The 2020 Evercore ISI 3rd Annual HealthCONx Conference
11/25/2020
LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced that members of the executive management team will participate in a virtual fireside chat at the 3 rd Annual Evercore ISI HealthCONx Conference on Thursday, Dec. 3 at 1:50 p.m. ET. A live webcast of the presentation will be available via the company website at www.LabC
-
Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)
11/17/2020
Consortium aims to make comprehensive genomic profiling accessible to advanced cancer patients in the U.S. to inform medical management and improve patient outcomes.
-
LabCorp Is Scheduled to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference
11/2/2020
LabCorp (NYSE: LH) today announced that members of the executive management team will participate in a virtual fireside chat at the 29 th Annual Credit Suisse Virtual Healthcare Conference on Monday, Nov. 9 at 8:00 a.m. ET. A live audio webcast of the presentation will be available via the company website at www.LabCorp.com and archived for replay. About LabCorp LabCorp (NYSE: LH), an S&P 500 comp
-
LabCorp Announces 2020 Third Quarter Results
10/27/2020
LabCorp announced results for the third quarter ended September 30, 2020.
-
LabCorp Transforms the Clinical Trial Experience And Streamlines the Drug Development Process
10/20/2020
Advancements in Technology and Patient Access Deliver Better Clinical Trial Access, Quality, and Experiences